In The News

11.14.16

Prescription Drug Prices Still a Top Concern for Voters

Politico quoted Manatt’s Ian Spatz, a senior advisor with Manatt Health, for an article highlighting the importance of prescription drug prices to voters in the U.S.Spatz said the industry’s initial reaction to the election was “shock and surprise” and “caused everyone ...


11.18.15

AMA Calls for Ban on Prescription Drug Advertising

Marketplace interviewed Manatt's Ian Spatz, a senior advisor in the firm's Healthcare practice, for an article on the American Medical Association's call to ban direct-to-consumer advertising of prescription drugs and medical devices. The group says the advertisements are boosting ...


03.11.14

Law360 Speaks to Manatt Professional on CMS' Withdrawal of Medicare Part D Proposals

Law360 interviewed Manatt's Ian Spatz, a senior advisor in the firm's Healthcare Division, about the Centers for Medicare and Medicaid Services' retreat from a major overhaul of Medicare Part D.Law360 reports that the proposed rule, whose biggest components have been largely ...


01.08.14

Drug Industry Daily Quotes Manatt Professional on CMS Plan for Antidepressants

Drug Industry Daily quoted Manatt's Ian Spatz, a senior advisor in the firm's Healthcare Division, on the Centers for Medicare & Medicaid Services' (CMS) plan to force makers of antidepressants and immunosuppressants to compete for inclusion on Medicare Part D formularies, which it ...